80 related articles for article (PubMed ID: 21393873)
41. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
42. Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer.
Zhong WD; Chen QB; Ye YK; Han ZD; Bi XC; Dai QS; Liang YX; Zeng GH; Wang YS; Zhu G; Chen ZN; He HC
Cancer Epidemiol; 2010 Aug; 34(4):478-82. PubMed ID: 20483678
[TBL] [Abstract][Full Text] [Related]
43. Fascin, cortactin and survivin expression of melanocytic neoplasms and association with clinicopathological parameters and anatomic locations in Chinese people.
Gao HW; Yu CP; Lee HS; Nieh S; Chiang CP; Wang WM; Jin JS
Eur J Dermatol; 2010; 20(3):293-301. PubMed ID: 20400386
[TBL] [Abstract][Full Text] [Related]
44. CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Transl Res; 2008 Sep; 152(3):143-9. PubMed ID: 18774544
[TBL] [Abstract][Full Text] [Related]
45. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
Nabeshima K; Iwasaki H; Nishio J; Koga K; Shishime M; Kikuchi M
Anticancer Res; 2006; 26(2B):1359-67. PubMed ID: 16619545
[TBL] [Abstract][Full Text] [Related]
46. Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis.
Tan VY; Lewis SJ; Adams JC; Martin RM
BMC Med; 2013 Feb; 11():52. PubMed ID: 23442983
[TBL] [Abstract][Full Text] [Related]
47. Higher expression of epidermal growth factor receptor is associated with extracellular matrix metalloprotease inducer in colorectal adenocarcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Wu CY; Lin YF; Wang JY; Yu CP; Sheu LF; Chiang H; Tsai WC; Lee WH
Dis Markers; 2006; 22(5-6):309-16. PubMed ID: 17264401
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters.
Tsai WC; Chao YC; Sheu LF; Chang JL; Nieh S; Jin JS
Dis Markers; 2007; 23(3):153-60. PubMed ID: 17473384
[TBL] [Abstract][Full Text] [Related]
49. The actin-bundling protein fascin is overexpressed in colorectal adenomas and promotes motility in adenoma cells in vitro.
Qualtrough D; Singh K; Banu N; Paraskeva C; Pignatelli M
Br J Cancer; 2009 Oct; 101(7):1124-9. PubMed ID: 19738613
[TBL] [Abstract][Full Text] [Related]
50. Expression of extracellular matrix metalloproteinase inducer and fascin in urinary bladder cancer: Correlation with clinicopathological characteristics.
El-Rehim DM; El-Maqsoud NM; El-Hamid AM; El-Bab TK; Galal EM
Mol Clin Oncol; 2013 Mar; 1(2):297-304. PubMed ID: 24649164
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical Study of Ezrin Expression in Colorectal Carcinoma: A Comparative Study between Objective Method and Digital Quantitative Assessment.
Ayad EE; Kamal Eldin YO; El-Hindawi AA; Abdelmagid MS; Elmeligy HA
Asian Pac J Cancer Prev; 2020 Apr; 21(4):967-974. PubMed ID: 32334457
[TBL] [Abstract][Full Text] [Related]
52. [Ovarian metastasis as the initial manifestation of a colorectal cancer].
Peña-Irún Á; Rodríguez-Guillén J; González-Santamaría AR
Semergen; 2015 Sep; 41(6):343-4. PubMed ID: 24768026
[No Abstract] [Full Text] [Related]
53. Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas.
Pignatelli M; Smith ME; Bodmer WF
Br J Cancer; 1990 Apr; 61(4):636-8. PubMed ID: 2158810
[No Abstract] [Full Text] [Related]
54. Fascin-1: Updated biological functions and therapeutic implications in cancer biology.
Li CH; Chan MH; Liang SM; Chang YC; Hsiao M
BBA Adv; 2022; 2():100052. PubMed ID: 37082587
[TBL] [Abstract][Full Text] [Related]
55. Tracking the Antibody Immunome in Sporadic Colorectal Cancer by Using Antigen Self-Assembled Protein Arrays.
González-González M; Sayagués JM; Muñoz-Bellvís L; Pedreira CE; de Campos MLR; García J; Alcázar JA; Braz PF; Galves BL; González LM; Bengoechea O; Abad MDM; Cruz JJ; Bellido L; Fonseca E; Díez P; Juanes-Velasco P; Landeira-Viñuela A; Lecrevisse Q; Montalvillo E; Góngora R; Blanco O; Sánchez-Santos JM; LaBaer J; Orfao A; Fuentes M
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072782
[TBL] [Abstract][Full Text] [Related]
56. Emerging Role of Fascin-1 in the Pathogenesis, Diagnosis, and Treatment of the Gastrointestinal Cancers.
Ristic B; Kopel J; Sherazi SAA; Gupta S; Sachdeva S; Bansal P; Ali A; Perisetti A; Goyal H
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064154
[TBL] [Abstract][Full Text] [Related]
57. Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target?
Liu H; Zhang Y; Li L; Cao J; Guo Y; Wu Y; Gao W
Mol Ther Oncolytics; 2021 Mar; 20():240-264. PubMed ID: 33614909
[TBL] [Abstract][Full Text] [Related]
58. Roles of Fascin mRNA expression in colorectal cancer: Meta-analysis and bioinformatics analysis.
Shi S; Zheng HC; Zhang- ZG
Mol Clin Oncol; 2020 Aug; 13(2):119-128. PubMed ID: 32714534
[TBL] [Abstract][Full Text] [Related]
59. The meta and bioinformatics analysis of fascin expression in gastric cancer: a potential marker for aggressiveness and worse prognosis.
Zheng HC; Zhao S
Oncotarget; 2017 Dec; 8(62):105574-105583. PubMed ID: 29285273
[TBL] [Abstract][Full Text] [Related]
60. Prognostic role of extracellular matrix metalloproteinase inducer/CD147 in gastrointestinal cancer: a meta-analysis of related studies.
Huang X; Shen W; Xi H; Zhang K; Cui J; Wei B; Chen L
Oncotarget; 2016 Dec; 7(49):81003-81011. PubMed ID: 27768590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
